New custom-designed patient shielding devices should supplant traditional lead aprons for chest CT scans - and possibly every scan, regardless of body part. That’s according to the authors of a new study published in the British Journal of Radiology.
New custom-designed patient shielding devices should supplant traditional lead aprons for chest CT scans - and possibly every scan, regardless of body part. That’s according to the authors of a new study published in the British Journal of Radiology.
Medical physicist Gareth Iball, MSc, and colleagues at the Leeds General Infirmary used dosimeters to measure radiation levels throughout the abdomen and pelvis during chest CT scans of a RANDO phantom. Dose measurements were made with no shielding, with lead aprons and with the new shield around the abdomen and pelvis to quantify the achievable organ and effective dose reductions.
With the new out-of-plane shielding devices in place, Ball and colleagues measured “significant dose savings” throughout the abdomen and pelvis. All told, the new shielding provided effective dose saving of 4 percent over that obtained through conventional lead aprons.
“This could yield significant population dose savings and reductions in collective radiation risk,” the authors wrote.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
Can CT-Based Deep Learning Bolster Prognostic Assessments of Ground-Glass Nodules?
June 19th 2025Emerging research shows that a multiple time-series deep learning model assessment of CT images provides 20 percent higher sensitivity than a delta radiomic model and 56 percent higher sensitivity than a clinical model for prognostic evaluation of ground-glass nodules.